IP Library Granted Patent US 10,857,350
Granted Patent B2
US 10,857,350 · App. 15/988,452 · Granted Dec 8, 2020

Lead splitter for neurostimulation systems

Inventor: Paul M. Meadows (Glendale, CA)
Assignee: ImThera Medical, Inc.
A61N1/0556A61N1/36125A61N1/3752A61N1/37217
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,857,350
App. No.
15/988,452
Granted
Dec 8, 2020
Kind
B2
Abstract

A device comprises an implantable pulse generator having a plurality of stimulator outputs and a plurality of neutral electrodes. A lead splitter is configured to electronically map the stimulator outputs to the plurality of neutral electrodes. The present invention generally relates to implanted neurostimulation systems and, more particularly, to a lead splitter for neurostimulation systems and methods to increase the number of effective output channels of a single or multi-channel neurostimulator.

Claims (24)

1. A system comprising:

an implantable pulse generator having a plurality of stimulator outputs each providing a plurality of stimulator pulses;

a first lead having a first plurality of electrodes each configured to stimulate a portion of a first nerve;

a second lead having a second plurality of electrodes each configured to stimulate a portion of a second nerve; and

a lead splitter electrically coupled between the implantable pulse generator and the first plurality and second plurality of electrodes and configured to selectively assign the plurality of stimulator outputs to the first plurality of electrodes and the second plurality of electrodes to deliver the plurality of stimulator pulses from the implantable pulse generator to the first plurality of electrodes and the second plurality of electrodes,

wherein the lead splitter is an electronic lead splitter programmable to permit reconfigurable assignment of the plurality of stimulator outputs to the first plurality of electrodes and the second plurality of electrodes.

2. The system of claim 1 , wherein a total number of the plurality of stimulator outputs is equal to a total number of the first plurality of electrodes and is equal to a total number of the second plurality of electrodes.

3. The system of claim 1 , wherein the first plurality of electrodes are coupled to a first cuff configured to at least partially wrap around the first nerve such that the first plurality of electrodes are spaced on the first nerve, and

wherein the second plurality of electrodes are coupled to a second cuff configured to at least partially wrap around the second nerve such that the second plurality of electrodes are spaced on the second nerve.

4. The system of claim 1 , wherein the lead splitter requires power to selectively assign each of the plurality of stimulator outputs, the power being derived from the plurality of stimulation pulses.

5. The system of claim 4 , wherein the lead splitter requires data to selectively assign each of the plurality of stimulator outputs, the data being provided to the lead splitter using the plurality of stimulation pulses.

6. The system of claim 5 , wherein the implantable pulse generator uses pulse polarity and/or phase of the plurality of stimulation pulses to encode the data.

7. The system of claim 5 , wherein the implantable pulse generator uses multiple pulse phases to encode the data.

8. The system of claim 5 , wherein the implantable pulse generator uses pulse phase duration to encode the data.

9. The system of claim 5 , wherein the implantable pulse generator uses pulse frequency to encode the data.

10. The system of claim 4 , wherein the lead splitter is configured to control whether or not the plurality of stimulation pulses are passed to the first plurality of electrodes and/or the second plurality of electrodes.

11. The system of claim 4 , wherein the lead splitter is able to pass data to a secondary lead splitter allowing multiple lead splitters to be attached in sequence to a single port of the implantable pulse generator.

12. The system of claim 1 , wherein the lead splitter is configured to pass data back to the implantable pulse generator.

13. The system of claim 12 , wherein the lead splitter is configured to communicate back to the implantable pulse generator by one or more of impedance or load, RF telemetry, optical telemetry, and AC modulation.

14. The system of claim 12 , wherein the data contains one or more of electrode contact impedance, status of the lead splitter, power condition of the lead splitter including state of charge and/or elective replacement indicator information, and memory storage information retrieved by the implantable pulse generator using commands from the implantable pulse generator to the lead splitter to read from or write to memory storage of the lead splitter.

15. The system of claim 1 , wherein the lead splitter is configured to disconnect connections to the first plurality of electrodes and/or the second plurality of electrodes to protect tissue from effects of one or more of an MRI, electrocautery, and defibrillation or other potentially harmful electromagnetic conditions or environments.

16. The system of claim 1 , wherein the lead splitter contains or connects to one or more sensors configured to provide information to the lead splitter or an external controller.

17. The system of claim 16 , wherein the lead splitter is configured to pre-process the information and transfer that information to the implantable pulse generator or the external controller.

18. The system of claim 16 , wherein the lead splitter and the implantable pulse generator are configured to communicate with one another through polled or interrupt methods.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: ACF FINCO I LP
To: IMTHERA MEDICAL, INC.
Reel/Frame 057535/0850 →
SECURITY INTEREST Recorded Aug 16, 2021
From: IMTHERA MEDICAL, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0115 →
RELEASE OF SECURITY INTEREST Recorded Aug 16, 2021
From: ARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERS
To: IMTHERA MEDICAL, INC.
Reel/Frame 057188/0573 →
PATENT SECURITY AGREEMENT Recorded Dec 30, 2020
From: IMTHERA MEDICAL, INC.
To: ACF FINCO I LP, AS COLLATERAL AGENT
Reel/Frame 054881/0683 →
PATENT SECURITY AGREEMENT Recorded Jun 17, 2020
From: IMTHERA MEDICAL, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 052963/0651 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2018
From: MEADOWS, PAUL M.
To: IMTHERA MEDICAL, INC.
Reel/Frame 046197/0712 →
Continuity (3)
Continuation 14771625
Provisional Application 61773926 · Mar 7, 2013
Related Publication 20180264269A1 · Sep 20, 2018